JW Pharmaceutical (XKRX:001060) Construction In Progress : ₩7,489 Mil (As of Mar. 2024)

View and export this data going back to 1976. Start your Free Trial

What is JW Pharmaceutical Construction In Progress?

JW Pharmaceutical's quarterly construction in progress declined from Sep. 2023 (₩7,117 Mil) to Dec. 2023 (₩6,064 Mil) but then increased from Dec. 2023 (₩6,064 Mil) to Mar. 2024 (₩7,489 Mil).

JW Pharmaceutical's annual construction in progress increased from Dec. 2021 (₩849 Mil) to Dec. 2022 (₩8,128 Mil) but then declined from Dec. 2022 (₩8,128 Mil) to Dec. 2023 (₩6,064 Mil).

JW Pharmaceutical Construction In Progress Historical Data

The historical data trend for JW Pharmaceutical's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Pharmaceutical Construction In Progress Chart

JW Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Get a 7-Day Free Trial

986.83

4,075.25

849.45

8,127.60

6,064.34

JW Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial															6,922.15	9,020.76	7,116.84	6,064.34	7,489.39

JW Pharmaceutical Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

JW Pharmaceutical (XKRX:001060) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001060) » Definitions » Construction In Progress

Traded in Other Exchanges

001067:Korea 001065.PFD:Korea

Address

2477, Nambusunhwan-ro, Seocho-gu, KOR

Website

https://www.jw-pharma.co.kr

JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.

JW Pharmaceutical (XKRX:001060) Headlines

No Headlines